Workboat Indexes

Markets:

Overview

News

Currencies

International

Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

128.31 -5.31 (-3.97%)

Streaming Delayed Price Updated: 1:16 PM EDT, Jun 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

“Threading The Needle” Stock Market (And Sentiment Results) ↗

May 05, 2022

Two weeks ago AAII sentiment survey dropped to a 30 year low at 15.8% bullish. Last week it ticked up modestly to 16.4%.

Via Talk Markets

7 Monster Stock Market Predictions For The Week Of April 25 ↗

April 23, 2022

The week ending April 22 was brutal. The S&P 500 fell by nearly 2.75%, but things were much worse than that. Powell unleashed hell when he noted that a 50 bps rate hike was on the table for the FOMC...

Via Talk Markets

The “magic Chart” Stock Market (And Sentiment Results) ↗

April 21, 2022

We have now come to a point Where the market has priced in more rate hikes than are likely to occur.

Via Talk Markets

4 Undervalued Biotech Stocks to Add to Your Buy List ↗

April 20, 2022

These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns.

Via InvestorPlace

Healthcare Stocks Lead the Way Up as the Market Fades ↗

April 11, 2022

With inflation and energy costs soaring, the Fed ever threatening with higher rates and headlines from the war in Ukraine investors are seeking more defensive positions.

Via Talk Markets

The “Shake It Off” Stock Market (And Sentiment Results) ↗

April 07, 2022

We may be close to a short term peak in yields – bottom in bonds

Via Talk Markets

XBI Biotech 15% Potential ↗

February 08, 2022

The Biotech Sector ETF had a very nice rally, a bull flag, and ended up having the second half of the move to the upside.

Via Talk Markets

Recession Fears are Creating a Golden Opportunity for Biotech Stocks ↗

April 08, 2022

Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now.

Via InvestorPlace

Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks ↗

April 08, 2022

Cash will be king in biotech picks like BLUE stock as governments slow approvals and reimbursements of new gene therapies.

Via InvestorPlace

Sunshine Biopharma Stock Triples on Positive mRNA Cancer Treatment Results ↗

April 05, 2022

SBFM stock tripled to $6.53 on Tuesday after revealing that two of its newly designed mRNA molecules are effective in destroying cancer cells.

Via InvestorPlace

Good Entry Point for Biotech Stocks ↗

April 04, 2022

Life science and biotech stocks had a good week with the most well-known ETFs up 3-4% for the week and off recent bottoms.

Via Talk Markets

CNBC's Final Call: Newmont, Biotech ETF And This Energy Stock ↗

April 04, 2022

On CNBC's "The Final Call," Carter Worth recommended Newmont Corporation (NYSE: NEM). The stock has jumped almost 36% year to date.

Via Benzinga

Acadia: Helping With Alzheimers And Parkinsons ↗

April 03, 2022

Things always change fast in biotech, but until recently things have been moving consistently to the downside. It’s been a while, but we believe this is finally over. And we believe Acadia...

Via Talk Markets

Biotech Funds and ETFs Continue to Lag ↗

March 28, 2022

It’s no secret that market sectors driving inflation are leading the market. With the US economy still strong and the War in Ukraine limiting supply of nat gas and raw materials, producer costs are...

Via Talk Markets

How do Biotechnology Funds and ETFs Perform Over Five Years? ↗

March 21, 2022

Biotech investing can be difficult for short-term traders but can offer good returns over five years if balanced with other healthcare positions like the XLV.

Via Talk Markets

AskSlim Market Week - Friday, March 18 ↗

March 18, 2022

Technical and cycle analysis, and market commentary.

Via Talk Markets

3 Market ETF Stocks to Buy This Week on Fed Jitters ↗

March 14, 2022

The bears have two major tailwinds and the Fed is one. Here are 3 ETF stocks to buy into a potential relief rally after the event blows over.

Via InvestorPlace

Tough Slogging Ahead for Investors, Diversification is Important ↗

March 07, 2022

Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows.

Via Talk Markets

3 Moonshot Stocks Insiders Are Buying. What Do They Know? ↗

February 25, 2022

Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares. These three all offer that enticing feature.

Via InvestorPlace

3 Desirable Drug Stocks With Very Promising Pipelines ↗

February 16, 2022

Drug makers with superb pipelines are likely to deliver great returns for long-term investors. Here are three drug stocks to consider.

Via InvestorPlace

Large Cap Biopharma- Well Positioned For Choppy Markets ↗

February 14, 2022

If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets.

Via Talk Markets

The Dean Martin, “You’re Nobody ‘Till Somebody Loves You” Stock Market (And Sentiment Results)… ↗

February 11, 2022

China Tech (Alibaba) and Biotech have been the two least-loved sectors in recent weeks, but we believe this is changing.

Via Talk Markets

Small Cap Biotech Stocks: Is it time to start trading? ↗

January 31, 2022

It’s time to trade beaten-up small cap biotech stocks.

Via Talk Markets

3 Pharma Stocks Yielding Over 3% ↗

January 18, 2022

The Pharma industry faced headwinds in 2021 as hospitals delayed procedures and elective surgeries.

Via Talk Markets

9 Monster Stock Market Predictions – The Week Of Jan. 17 ↗

January 17, 2022

The chart for the SPX is looking more and more like a diamond pattern.

Via Talk Markets

3 Biotech Stocks to Buy That Are Under Severe Pressure ↗

January 13, 2022

The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.

Via InvestorPlace

Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer ↗

January 10, 2022

Pfizer and Bayer inked deals with several companies in gene-editing.

Via Investor's Business Daily

Whitney Tilson Names Cannabis ETF 'Favorite Pick For 2022' But Clock Is Ticking To Change US Regulations ↗

January 03, 2022

It was another brutal year for cannabis stock investors in 2021 as the U.S. made very little regulatory progress on cannabis reform measures. Fortu...

Via Benzinga

Fear & Greed In The Biotech Sector ↗

January 02, 2022

With rates rising, widespread tax-loss selling, and fund manager’s either closing the books for 2021 or just closing down altogether, the market has entered a major risk off phase and biotech stocks...

Via Talk Markets

Healthcare Stocks Are Winners And Provide Diversification To Your Portfolio ↗

December 30, 2021

As we have written their year many times speculative small cap biotechs have not done well in 2021 since they peaked in February.

Via Talk Markets

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Workboat Indexes

State Street SPDR S&P Biotech ETF (NY:XBI)

All News about State Street SPDR S&P Biotech ETF

Hyundai, BAR Technologies partner on wind-assisted propulsion

Davie breaks ground on $1 billion Gulf Copper shipyard modernization

Coast Guard, cruise ship crew rescue solo sailor 489 miles off Oregon

Financing the Build: How Commercial Marine Vessels Get Funded from Keel Laying to Delivery